July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
IVMED-80 Eye Drops for Treatment of Keratoconus
Author Affiliations & Notes
  • Sarah Molokhia
    iVeena Delivery Systems, Salt Lake City, Utah, United States
  • Santosh Kumar Kumar Muddana
    Moran Eye Center, Sandy, Utah, United States
  • Hironori Uehara
    Moran Eye Center, Sandy, Utah, United States
    iVeena Delivery Systems, Salt Lake City, Utah, United States
  • Michael Burr
    iVeena Delivery Systems, Salt Lake City, Utah, United States
  • Haeli hauritz
    iVeena Delivery Systems, Salt Lake City, Utah, United States
  • James McCulloch
    iVeena Delivery Systems, Salt Lake City, Utah, United States
  • Balamurali K Ambati
    Moran Eye Center, Sandy, Utah, United States
    iVeena Delivery Systems, Salt Lake City, Utah, United States
  • Footnotes
    Commercial Relationships   Sarah Molokhia, iVeena Delivery Systems (E); Santosh Kumar Muddana, None; Hironori Uehara, iVeena Delivery Systems (C); Michael Burr, iVeena Delivery Systems (E); Haeli hauritz, iVeena Delivery Systems (E); James McCulloch, iVeena Delivery Systems (E); Balamurali Ambati, iVeena Delivery Systems (I)
  • Footnotes
    Support  NIH-NEI R43EY027636
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4454. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sarah Molokhia, Santosh Kumar Kumar Muddana, Hironori Uehara, Michael Burr, Haeli hauritz, James McCulloch, Balamurali K Ambati; IVMED-80 Eye Drops for Treatment of Keratoconus. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4454.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : a)To study the safety and tolerability ofIVMED-80 eye drops (which activate lysyl oxidase and induce pharmacological corneal collagen crosslinking) in rabbit in vivo, b) study the effect of dosing frequency on rabbit corneal topography and radial strain measurements.

Methods : The safety and efficacy of IVMED-80 (copper-containing formulation) on rabbit corneas were investigated in 6 groups (n=8 each), including the three controls (no drops, artificial tears three times a day (3x/day) and BSS 3x/day) and three IVMED-80 treatment groups (low concentration (3x/day), low concentration (1x/day) and high concentration (3x/day)). Rabbits were tested for serum copper at baseline and at end points for copper toxicity. Intraocular pressures (IOPs) was measured with a floating tip tonometer prior to treatment and every week. Safety observations of the cornea and score irritation of conjunctiva and sclera including redness, chemosis, and discharge was performed weekly. Histopathological analysis (n=2) for high concentration IVMED 80 was evaluated by an ophthalmologist in all dissected eye tissues. Topography images were taken before treatment and weekly for 1 month to assess corneal curvature of specific areas in dioptric values. Diopter (D) measurements were the mean SIMK values. At week 1 and week 4 (n=4), rabbits were sacrificed and corneas were harvested. The rabbit corneas were coupled between a motor and a transducer that applied a controlled pressure from 5-30 mmHg, measuring the resultant radial strain as a measure of corneal elastic modulus (cornea stiffness).

Results : Histopathological analysis showed no observed toxicity in all dissected eye tissues treated with any concentration of IVMED 80 eye drops. IOP measurements were within normal limits 15-20 mmHg for all eyes during the study. IVMED-80 was effective in decreasing cornea diopter measurements compared to control treatments (Figure 1). IVMED-80 achieved improvement of corneal elastic modulus within 1 or 4 weeks of therapy to a level comparable to conventional crosslinking (C-CXL) at 4 weeks after laser surgery in rabbits.

Conclusions : We demonstrate that a new topical eye drop for keratoconus induces corneal flattening and stiffening without toxicity in rabbits.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×